Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

10 Worst “Strong Sell” Stocks This Week — EXK EGO NG and more

This week, these ten stocks have the worst year-to-date performance. Each of these also rates an "F" ("strong sell") on Portfolio Grader. Since the beginning of the year, the Nasdaq rose 10.9%, the Dow is up 13.2%, and the S&P has risen 12.1%.

5 Stocks With Crummy Earnings Surprises — WPC CBB ROMA MOD NX

This week, these five stocks have the worst ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader.

6 Energy Services Stocks to Sell Now

This week, the ratings of six Energy Services stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Software Stocks to Sell Now

For the current week, the overall ratings of four Software stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Construction and Engineering Stocks to Sell Now

The overall ratings of three Construction and Engineering stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Biotech Blowout: 3 Stocks Taking a Hit

The risky side of biotech stocks reared its ugly head in the past couple of days, sending three stocks to the mat in the wake of bad news.

Quality Is King This Q3 Earnings Season

Quality is going to matter during Q3 earnings season. Don't be caught owning the wrong stocks at what could be a devastatingly wrong time.

4 Stocks With Awful Earnings Momentum — FNBN NAV SGK LGCY

This week, these four stocks have the worst ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

7 Semiconductor Stocks to Sell Now

For the current week, the overall ratings of seven Semiconductor stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Biotechnology Stocks to Sell Now

This week, the ratings of seven Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Use Any JCP Jumps to Sell JCPenney Stock NOW

Don't be fooled by Tuesday's brief bout of optimism in JCP stock. JCPenney still faces a huge uphill climb to regain its losses, customers and dignity.

Should I Buy GlaxoSmithKline (GSK)? 3 Pros, 3 Cons

GlaxoSmithKline is seeking approval for the world's first malaria vaccine, but high debt and low growth mean investors should think twice before buying.

5 Worst Blue Chips to Own Before Earnings

A close look at the Dow reveals five ugly blue chips that still are holding back the index -- and that investors should avoid if they want to profit in 2014.

5 Worst Sectors to Avoid This Week

This week, the Computer and Personal Electronics, Energy Services, Computer and Personal Electronics, Oil and Gas, and Marine sectors look weak according to Portfolio Grader.

5 Stocks With Ugly Earnings Growth — KWK GNK SOL CRK LM

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Poor Cash Flow — KWK STP ATPG EDN AONE

This week, these five stocks have the worst ratings in Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.

4 Capital Markets Stocks to Sell Now

The overall ratings of four Capital Markets stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Bad Operating Margin Growth — SYUT CTEL HKTV IMMU FMBI

This week, these five stocks have the worst ratings in Operating Margin Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Awful Sales Growth — NAVB CTEL HKTV CUR IMMU

This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.